ATX-101

Allay’s ATX101 offers post-surgical pain relief in Phase IIB trial
Clinical Trials Arena
Fri, 04/12/24 - 11:00 am
Allay Therapeutics
clinical trials
post-surgical pain
ATX-101
A Drug That Destroys Fat Cells Could Make Kythera's Stock Look Beautiful
Seeking Alpha
Sat, 04/25/15 - 09:27 am
Kythera
ATX-101
FDA
Kythera's double chin injection rolls toward FDA approval
Fierce Biotech
Fri, 03/6/15 - 11:20 am
Kythera Biopharmaceuticals
FDA
double chin
ATX-101
Kythera announces FDA acceptance of ATX-101 NDA
Yahoo/Fly on the Wall
Thu, 07/10/14 - 05:43 pm
FDA
ATX-101
Kythera
double chin
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
Kythera buys back Bayer's stake in PhIII chin-fat therapy in $84M deal
Fierce Biotech
Tue, 03/11/14 - 11:13 am
Kythera
Bayer
ATX-101
double chin
Kythera announces two Phase III trials meet primary, secondary endpoints
The Fly on the Wall
Tue, 09/17/13 - 09:32 am
Kythera
ATX-101
double chin
Kythera Pharmaceuticals: A Compelling Investment Opportunity With Potential Key Catalysts
Seeking Alpha
Wed, 08/7/13 - 09:13 am
Kythera
ATX-101
KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Phase IIIb Study of ATX-101 at the 11th Anti-Aging Medicine World Congress (AMWC)
Yahoo/BusinessWire
Sat, 04/6/13 - 11:07 am
ATX-101
Kythera Biopharmaceuticals
KYTHERA Biopharmaceuticals, Inc. to Present New Data at 2013 American Academy of Dermatology (AAD) Annual Meeting Demonstrating Results for ATX-101 in the Reduction of Submental Fat (SMF) or “Double Chin”
Yahoo/BusinessWire
Sat, 03/2/13 - 04:03 pm
ATX-101
obesity
weight loss
Kythera Biopharmaceuticals